Industry Voice sat down with Christophe Griolet, General Manager of Gilead Sciences Canada, to discuss how he applies global learnings in a local context, his commitment to health equity, and the incredible promise of personalized medicine.
It takes on average more than 2 years following a launch for a given drug to be available to Canadians through public drug plans.